Tag: MindRank
MindRank hands China rights to its AI-designed obesity pill
The Hangzhou biotech gives two 3SBio units exclusive China commercialization for MDR-001 in a deal worth up to RMB 1.75B.
The Hangzhou biotech gives two 3SBio units exclusive China commercialization for MDR-001 in a deal worth up to RMB 1.75B.